Medicare recently announced that its Part B outpatient premium will increase…
Prescription drug costs continue to be a concern for many Americans….
According to the World Health Organization, cardiovascular disease is the leading…
Entrepreneur Nutte Van Belzen of CC Diagnostics recently won the 2019…
Suitable animal models are an unavoidable necessity in the testing and…
As a pioneer with the Standard for Exchange Nonclinical Data (SEND)…
Wish I May is a volunteer-run 501(c)(3) non-profit organization in the Springfield,…
Did you know that 23.6 percent of the world’s pharmaceutical companies…
Two power women currently ‘man’ the Business Development (BD) department at…
Later this month the United Kingdom (UK) is expected to achieve…
For outstanding performance including growth in sales, continuous growth in minority…
Mr. Sanjay Mitter joined QPS as VP and Global Head of…
Since 2012, a New Investigator Award has been given annually to…
QPS CEO Ben Chien has made it through to the round…
Each year, Life Science Leader honors CROs that are the top…
Where do you turn when you just took the package? 25%…
Cancer immuno therapies. Oligo therapeutics. CAR T-cell therapies. Breakthrough Antivirals. For…
The past 20 years for QPS have included countless hours of…
When I reflect on the past 20 years of my life,…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
NEWARK, Delaware, November 13, 2024/BUSINESS WIRE/ — QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy…
Webinars
Medicare: Rising Premiums and Novel AD Drugs
January 12, 2022
Medicare recently announced that its Part B outpatient premium will increase by $21.60 per month in 2022. The increase marks one of Medicare’s largest premium
How Congress Could Regulate Medicare Drug Prices
December 1, 2021
Prescription drug costs continue to be a concern for many Americans. But now, as Congress works to finalize President Biden’s Build Back Better social spending
Aiding in the Development of Cardiovascular Drugs
January 13, 2020
According to the World Health Organization, cardiovascular disease is the leading cause of death in the United States and worldwide. In fact, about 17.9 million
QPS Physician Nutte Van Belzen Wins 2019 Young Entrepreneur Award
December 20, 2019
Entrepreneur Nutte Van Belzen of CC Diagnostics recently won the 2019 Jonge Ondernemingsprijs (Young Entrepreneur Award). Van Belzen also happens to work as a part-time
Establishing Preclinical Leadership in Asia with the Addition of Mini Pig Studies
August 19, 2019
Suitable animal models are an unavoidable necessity in the testing and development of new pharmacological agents. QPS has an extensive history of conducting studies in
Establishing Leadership in Asia with SEND
August 12, 2019
As a pioneer with the Standard for Exchange Nonclinical Data (SEND) system in Asia, QPS Taiwan CTPS has taken a leadership role in implementing and
QPS Missouri Collaborates with Local Agency to Bring Birthday Celebrations to Underserved Children
August 8, 2019
Wish I May is a volunteer-run 501(c)(3) non-profit organization in the Springfield, Missouri, community striving to make a difference one child and one birthday at a
QPS Celebrating Sustained Growth in Asia
June 24, 2019
Did you know that 23.6 percent of the world’s pharmaceutical companies are now located in Asia? That’s up from 20.5 percent in 2018 – a
Power Women in Business Development at QPS Netherlands
June 13, 2019
Two power women currently ‘man’ the Business Development (BD) department at QPS Netherlands, in close collaboration with the Head of BD, Edwin van Vulpen, MBA,
QPS: Young at Heart
May 9, 2019
At QPS, we work with a team of Research Physicians, who are all young professionals pursuing a career in Drug Development and/or Clinical Pharmacology. For
BREXIT IMPACT: More Questions Than Answers
March 30, 2019
Later this month the United Kingdom (UK) is expected to achieve independence from the European Union (EU) based on a referendum that was passed in
QPS Is Eastern Minority Supplier Development Council (EMSDC) 2016 Class IV Supplier of the Year
December 5, 2016
For outstanding performance including growth in sales, continuous growth in minority business to minority business purchases, innovation in the delivery of services, significant and continuous
Sanjay Mitter new VP and Global Head of Clinical Research Services
September 14, 2016
Mr. Sanjay Mitter joined QPS as VP and Global Head of Clinical Research Services. He is currently responsible for Clinical Research, i.e. global pharmacokinetics, data
QPS Netherlands scientist Daniel Wilffert nominated for New Investigator Award by Bioanalysis Zone!
June 22, 2016
Since 2012, a New Investigator Award has been given annually to honor excellence among bioanalytical scientists within their first five years in the industry. In
Ben Chien is an EY Entrepreneur Of The Year® 2016 Finalist for Greater Philadelphia!
May 17, 2016
QPS CEO Ben Chien has made it through to the round of 30 (31, actually) being considered for this year’s prestigious EY Entrepreneur Of The
Another CRO Leadership Award! For Compatibility, Expertise, Quality and Reliability
May 17, 2016
Each year, Life Science Leader honors CROs that are the top performers in Compatibility, Capabilities, Expertise, Quality, and Reliability. To determine the winners, the magazine
QPS Seen As Inspirational for Delaware
February 25, 2016
Where do you turn when you just took the package? 25% of DuPont employees (likely more on the way) got the bad news here in
Wishing You a Very Happy New Year, With Some Very Cool Science
December 16, 2015
Cancer immuno therapies. Oligo therapeutics. CAR T-cell therapies. Breakthrough Antivirals. For the past 20 years, we’ve been following the path of solid science and it’s
Growth and Goals-Our Next 10 Years: QPS 20th Anniversary Series, Part 6
October 28, 2015
The past 20 years for QPS have included countless hours of hard work, exciting change and a tireless commitment to do what is right for
The QPS Strategy for Overcoming Business Challenges: QPS 20th Anniversary Series, Part 5
October 26, 2015
When I reflect on the past 20 years of my life, I remember both the milestones and the few challenges I encountered along the way.
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
NEWARK, Delaware, November 13, 2024/BUSINESS WIRE/ — QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy…
